|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PARRIS N. GLENDENING, Governor
|
|
Ch. 153
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(II) $20 FOR A PRESCRIPTION FOR A PREFERRED BRAND NAME
DRUG; AND
(III) $35 FOR A PRESCRIPTION FOR A NONPREFERRED BRAND NAME
DRUG.
(B) THE BOARD MAY LIMIT THE TOTAL ANNUAL BENEFIT TO $1,000 PER
INDIVIDUAL.
(C) (1) THE BOARD, BY REGULATION, SHALL ADOPT A PRESCRIPTION DRUG
FORMULARY FOR THE PROGRAM.
(2) THE BOARD MAY EXCLUDE FROM THE PROGRAM'S FORMULARY ANY
EXPERIMENTAL DRUG THAT IS NOT APPROVED BY THE FEDERAL FOOD AND DRUG
ADMINISTRATION FOR GENERAL USE SUBJECT TO APPROVAL BY THE BOARD, THE
CARRIER THAT ADMINISTERS THE PROGRAM SHALL DEVELOP A PRESCRIPTION
DRUG FORMULARY TO BE USED IN THE PROGRAM.
14-513.
(A) PREMIUMS COLLECTED FOR THE PROGRAM SHALL BE DEPOSITED TO A
SEGREGATED ACCOUNT IN THE FUND ESTABLISHED UNDER § 14-504 OF THIS
SUBTITLE.
(B) IN ADDITION TO PREMIUM INCOME, THE SEGREGATED ACCOUNT SHALL
INCLUDE:
(I) INTEREST AND INVESTMENT INCOME ATTRIBUTABLE TO
PROGRAM FUNDS; AND
(II) MONEY DEPOSITED TO THE ACCOUNT BY THE CARRIER THAT
ADMINISTERS THE PROGRAM IN ACCORDANCE WITH SUBSECTION (C) OF THIS
SECTION.
(C) (1) BY JUNE 30 OF EACH YEAR, ON OR BEFORE APRIL 1, 2003 AND
QUARTERLY THEREAFTER THE PROGRAM ADMINISTRATOR SHALL DEPOSIT TO THE
FUND UNDER § 14-504 OF THIS SUBTITLE:
(I) PREMIUMS COLLECTED; AND
(II) THE AMOUNT, IN EXCESS OF PREMIUMS COLLECTED, THAT IS
NECESSARY TO OPERATE AND ADMINISTER THE PROGRAM FOR THE NEXT 12
MONTHS FOLLOWING QUARTER.
(2) THE AMOUNT DEPOSITED SHALL BE DETERMINED BY THE BOARD
BASED ON ENROLLMENT, EXPENDITURES, AND REVENUE FOR THE PREVIOUS YEAR
(3) THE AMOUNT REQUIRED BY THE BOARD UNDER PARAGRAPH (2) OF
THIS SUBSECTION MAY NOT EXCEED THE VALUE OF THE PROGRAM
ADMINISTRATOR'S ANNUAL PREMIUM TAX EXEMPTION UNDER § 6-101(B) OF THIS
ARTICLE.
|
|
|
|
|
|
|
|
|
|
- 1551 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
